SPEAR T-cell therapy (NY-ESO-1 targeting)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SPEAR T-cell therapy (NY-ESO-1 targeting), covering 2025-03-04 to 2025-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination